Cas no 55317-53-8 (2-(1H-Pyrazol-1-yl)benzoic acid)
2-(1H-Pyrazol-1-yl)benzoic acid Chemical and Physical Properties
Names and Identifiers
-
- 2-(1H-Pyrazol-1-yl)benzoic acid
- CHEMBRDG-BB 4400950
- 2-PYRAZOL-1-YL-BENZOIC ACID
- benzoic acid, 2-(1H-pyrazol-1-yl)-
- 2-(1-Pyrazolyl)benzoic Acid
- 2-pyrazol-1-ylbenzoic acid
- 2-(Pyrazol-1-yl)benzoic acid
-
- MDL: MFCD03086184
- Inchi: 1S/C10H8N2O2/c13-10(14)8-4-1-2-5-9(8)12-7-3-6-11-12/h1-7H,(H,13,14)
- InChI Key: MHACZVWKWUMHRR-UHFFFAOYSA-N
- SMILES: OC(C1C=CC=CC=1N1C=CC=N1)=O
Computed Properties
- Exact Mass: 188.05900
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 4
- Heavy Atom Count: 14
- Rotatable Bond Count: 2
- Complexity: 220
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Surface Charge: 0
- Tautomer Count: nothing
- XLogP3: 1.4
Experimental Properties
- Density: 1.28±0.1 g/cm3 (20 oC 760 Torr),
- Melting Point: 190 °C
- Boiling Point: 365.1℃ at 760 mmHg
- Flash Point: 174.6℃
- Solubility: Slightly soluble (2.1 g/l) (25 o C),
- PSA: 55.12000
- LogP: 1.57050
2-(1H-Pyrazol-1-yl)benzoic acid Customs Data
- HS CODE:2933199090
- Customs Data:
China Customs Code:
2933199090Overview:
2933199090. Other structurally non fused pyrazole ring compounds. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date
Summary:
2933199090. other compounds containing an unfused pyrazole ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
2-(1H-Pyrazol-1-yl)benzoic acid Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Matrix Scientific | 040325-500mg |
2-(1H-Pyrazol-1-yl)benzoic acid |
55317-53-8 | 500mg |
$126.00 | 2023-09-11 | ||
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | D851688-5g |
2-(1-Pyrazolyl)benzoic Acid |
55317-53-8 | ≥97% | 5g |
1,160.00 | 2021-05-17 | |
| Fluorochem | 065672-1g |
2-(1H-Pyrazol-1-yl)benzoic acid |
55317-53-8 | 97% | 1g |
£37.00 | 2022-03-01 | |
| Fluorochem | 065672-2.5g |
2-(1H-Pyrazol-1-yl)benzoic acid |
55317-53-8 | 97% | 2.5g |
£82.00 | 2022-03-01 | |
| Fluorochem | 065672-5g |
2-(1H-Pyrazol-1-yl)benzoic acid |
55317-53-8 | 97% | 5g |
£129.00 | 2022-03-01 | |
| Fluorochem | 065672-25g |
2-(1H-Pyrazol-1-yl)benzoic acid |
55317-53-8 | 97% | 25g |
£548.00 | 2022-03-01 | |
| TRC | P842215-10mg |
2-(1H-Pyrazol-1-yl)benzoic Acid |
55317-53-8 | 10mg |
$ 50.00 | 2022-06-03 | ||
| TRC | P842215-50mg |
2-(1H-Pyrazol-1-yl)benzoic Acid |
55317-53-8 | 50mg |
$ 65.00 | 2022-06-03 | ||
| TRC | P842215-100mg |
2-(1H-Pyrazol-1-yl)benzoic Acid |
55317-53-8 | 100mg |
$ 80.00 | 2022-06-03 | ||
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | P53420-1g |
2-(Pyrazol-1-yl)benzoic acid |
55317-53-8 | 1g |
¥328.0 | 2021-09-08 |
2-(1H-Pyrazol-1-yl)benzoic acid Related Literature
-
J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
-
Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
-
Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
-
Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
-
Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
Additional information on 2-(1H-Pyrazol-1-yl)benzoic acid
Comprehensive Overview of 2-(1H-Pyrazol-1-yl)benzoic acid (CAS No. 55317-53-8): Properties, Applications, and Industry Insights
2-(1H-Pyrazol-1-yl)benzoic acid (CAS No. 55317-53-8) is a versatile heterocyclic compound that has garnered significant attention in pharmaceutical and agrochemical research. This benzoic acid derivative, featuring a pyrazole ring, exhibits unique structural characteristics that make it valuable for drug discovery and material science applications. With the increasing demand for small molecule inhibitors and bioactive intermediates, this compound has become a focal point in modern organic synthesis.
The molecular structure of 2-(1H-Pyrazol-1-yl)benzoic acid combines a carboxylic acid functional group with a nitrogen-rich heterocycle, creating a multifunctional scaffold for medicinal chemistry. Researchers particularly value its ability to serve as a pharmacophore building block in the development of kinase inhibitors and anti-inflammatory agents. Recent studies have explored its potential in addressing oxidative stress-related disorders, aligning with current health trends focused on cellular protection and longevity.
In synthetic chemistry, CAS 55317-53-8 demonstrates remarkable versatility as a ligand precursor for transition metal complexes. Its chelating properties make it suitable for creating catalysts used in green chemistry applications, responding to the growing industry emphasis on sustainable processes. The compound's hydrogen bonding capacity also contributes to its utility in crystal engineering and supramolecular chemistry, areas gaining traction in advanced materials research.
From a commercial perspective, 2-(1H-Pyrazol-1-yl)benzoic acid has seen steady demand growth due to its role in developing next-generation therapeutics. Pharmaceutical companies are particularly interested in its application for targeted drug delivery systems, especially in oncology research where precision medicine approaches dominate current R&D strategies. The compound's structural modularity allows for diverse modifications, making it adaptable to various drug discovery platforms.
Analytical characterization of 55317-53-8 typically involves advanced techniques such as HPLC-MS and NMR spectroscopy, ensuring high purity standards required for research applications. Quality control protocols emphasize the compound's stability under various conditions, a critical factor for storage and handling in laboratory settings. Recent advancements in computational chemistry have enabled better prediction of its physicochemical properties, accelerating its application in virtual screening workflows.
The environmental profile of 2-(1H-Pyrazol-1-yl)benzoic acid has been evaluated through biodegradation studies, showing favorable results that align with green chemistry principles. This aspect has become increasingly important as regulatory bodies implement stricter guidelines for chemical sustainability. Manufacturers have responded by optimizing synthesis routes to minimize waste generation and energy consumption during production.
Emerging applications for CAS 55317-53-8 include its use in functional materials development, particularly in organic electronics and sensor technologies. The compound's electron-rich structure shows promise for creating novel conductive polymers and photovoltaic materials. These applications tap into the booming renewable energy sector, where researchers seek innovative organic compounds for energy storage solutions and light-harvesting systems.
Market analysis indicates growing interest in pyrazole-containing compounds across multiple industries, with 2-(1H-Pyrazol-1-yl)benzoic acid positioned as a key intermediate. The compound's patent landscape reveals numerous filings in medicinal chemistry applications, particularly in areas addressing metabolic disorders and neurodegenerative conditions - two of today's most pressing healthcare challenges.
From a regulatory standpoint, 55317-53-8 is generally recognized as safe for research purposes when handled according to standard laboratory protocols. Its toxicological profile has been extensively studied, with data supporting its use under controlled conditions. The compound's global availability through reputable chemical suppliers ensures consistent access for academic and industrial researchers worldwide.
Future research directions for 2-(1H-Pyrazol-1-yl)benzoic acid may explore its potential in bioconjugation chemistry and proteolysis targeting chimeras (PROTACs), two cutting-edge areas in drug development. The compound's ability to serve as a linker molecule in these complex systems could open new therapeutic possibilities, particularly in targeted protein degradation strategies that represent a paradigm shift in pharmaceutical science.
In conclusion, 2-(1H-Pyrazol-1-yl)benzoic acid (CAS No. 55317-53-8) stands as a remarkably adaptable chemical entity with broad relevance across scientific disciplines. Its unique structural features, combined with evolving applications in healthcare and materials science, ensure its continued importance in research and development. As scientific understanding of heterocyclic compounds deepens and technological capabilities advance, this molecule will likely play an increasingly significant role in addressing complex challenges across multiple industries.
55317-53-8 (2-(1H-Pyrazol-1-yl)benzoic acid) Related Products
- 264264-33-7(3-(1H-Pyrazol-1-yl)benzoic acid)
- 16209-00-0(4-(1H-Pyrazol-1-yl)benzoic acid)
- 956723-07-2(5-Methyl-2-(1H-pyrazol-1-yl)benzaldehyde)
- 138479-47-7(2-(1H-pyrazol-1-yl)benzaldehyde)
- 1186663-55-7(2-Amino-4-(1H-pyrazol-1-YL)benzoic acid)
- 1003502-76-8(4-methyl-3-(1H-pyrazol-1-yl)Benzoic acid)
- 169045-03-8(Benzoic acid,2-amino-5-(1H-pyrazol-1-yl)-)
- 1185294-89-6(4-(1H-Pyrazol-1-yl)benzoic acid hydrochloride)
- 1015845-87-0(3,5-Dimethyl-2-(1H-pyrazol-1-yl)benzaldehyde)
- 146139-53-9(Ethyl 2-(1H-pyrazol-1-yl)benzoate)